Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Orsolini

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
Frontiers in Psychiatry|October 16, 2020
Editorial: "No Words for Feelings, Yet!" Exploring Alexithymia, Disorder of Affect Regulation, and the "Mind-Body" ConnectionDomenico De Berardis, Michele Fornaro, Laura Orsolini
Expert Opinion on Drug Safety|July 14, 2020
Up-to-date expert opinion on the safety of recently developed antipsychoticsLaura Orsolini, Domenico De Berardis, Umberto Volpe
Psychoneuroendocrinology|September 20, 2025
High-sensitivity C-reactive protein as an early transdiagnostic biomarker for thoughts of death in mood disordersLaura Orsolini, Giulio Longo, Luciano Cavallo, et al.
Current Topics in Behavioral Neurosciences|June 9, 2016
NPS: Medical Consequences Associated with Their IntakeFabrizio Schifano, Laura Orsolini, Duccio Papanti, et al.
Asian Journal of Psychiatry|April 15, 2022
A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapyLaura Orsolini, Silvia Bellagamba, Virginio Salvi, et al.
International Review of Psychiatry (Abingdon, England)|February 14, 2023
The role of digital tools in providing youth mental health: results from an international multi-center studyLaura Orsolini, Cristina Appignanesi, Simone Pompili, et al.
Expert Opinion on Pharmacotherapy|January 8, 2024
An expert opinion on the pharmacological interventions for Disruptive Mood Dysregulation Disorder (DMDD)Laura Orsolini, Giulio Longo, Angelica Cicolini, et al.
Brain Sciences|December 23, 2023
The Novel Antipsychotic Lumateperone (Iti-007) in the Treatment of Schizophrenia: A Systematic ReviewGiulio Longo, Angelica Cicolini, Laura Orsolini, et al.
Frontiers in Psychiatry|May 28, 2024
"Swipe & slice": decoding digital struggles with non-suicidal self-injuries among youngstersLaura Orsolini, Salvatore Reina, Giulio Longo, et al.
Healthcare (Basel, Switzerland)|February 11, 2023
Foreign Nationality, Family Psychiatry History and Pregestational Neoplastic Disease as Predictors of Perinatal Depression in a Cohort of Healthy Pregnant and Puerperal Women during the COVID-19 PandemicLaura Orsolini, Simone Pompili, Antonella Mauro, et al.
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Frontiers in Psychiatry|October 16, 2020
Editorial: "No Words for Feelings, Yet!" Exploring Alexithymia, Disorder of Affect Regulation, and the "Mind-Body" ConnectionDomenico De Berardis, Michele Fornaro, Laura Orsolini
Expert Opinion on Drug Safety|July 14, 2020
Up-to-date expert opinion on the safety of recently developed antipsychoticsLaura Orsolini, Domenico De Berardis, Umberto Volpe
Psychoneuroendocrinology|September 20, 2025
High-sensitivity C-reactive protein as an early transdiagnostic biomarker for thoughts of death in mood disordersLaura Orsolini, Giulio Longo, Luciano Cavallo, et al.
Current Topics in Behavioral Neurosciences|June 9, 2016
NPS: Medical Consequences Associated with Their IntakeFabrizio Schifano, Laura Orsolini, Duccio Papanti, et al.
Asian Journal of Psychiatry|April 15, 2022
A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapyLaura Orsolini, Silvia Bellagamba, Virginio Salvi, et al.
International Review of Psychiatry (Abingdon, England)|February 14, 2023
The role of digital tools in providing youth mental health: results from an international multi-center studyLaura Orsolini, Cristina Appignanesi, Simone Pompili, et al.
Expert Opinion on Pharmacotherapy|January 8, 2024
An expert opinion on the pharmacological interventions for Disruptive Mood Dysregulation Disorder (DMDD)Laura Orsolini, Giulio Longo, Angelica Cicolini, et al.
Brain Sciences|December 23, 2023
The Novel Antipsychotic Lumateperone (Iti-007) in the Treatment of Schizophrenia: A Systematic ReviewGiulio Longo, Angelica Cicolini, Laura Orsolini, et al.
Frontiers in Psychiatry|May 28, 2024
"Swipe & slice": decoding digital struggles with non-suicidal self-injuries among youngstersLaura Orsolini, Salvatore Reina, Giulio Longo, et al.
Healthcare (Basel, Switzerland)|February 11, 2023
Foreign Nationality, Family Psychiatry History and Pregestational Neoplastic Disease as Predictors of Perinatal Depression in a Cohort of Healthy Pregnant and Puerperal Women during the COVID-19 PandemicLaura Orsolini, Simone Pompili, Antonella Mauro, et al.
Pageof 17